orchid pharma faces liquidation as lenders reject resolution plan
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.
.
the provider paid out on 7,469 life and 1,769 critical illness claims in the year, with men accounting for 59 per cent of life claims and 47 per cent of critical illness claims.
.
it shows that the longest waits for cancer treatment have soared since 2010.
.